MapLight Therapeutics, Inc. (MPLT) Institutional Ownership

Ownership Summary

MapLight Therapeutics, Inc. (NASDAQ:MPLT) is held by 81 institutional investors per 13F filings through March 2026.

• They owned 285.2% of outstanding stock in March 2026, down from 324.0% the prior quarter.
• They decreased total shares held in MapLight Therapeutics by -4.41% from last quarter, and the number of investors in MPLT stayed flat annually.
• During the quarter, 46 of these 81 funds increased positions in MPLT, 15 reduced exposure, and 20 held steady.
• Combined, these investors held 24.76Mn shares in MPLT for March 2026, down by 1.14Mn shares quarter on quarter, and with no net change year over year.
• As of March 31, 2026, the biggest holder of MapLight Therapeutics is Novo Holdings A/S at 3.69Mn shares, representing 42.47% of shares outstanding.
• Leading buyers of MapLight Therapeutics shares for the quarter ending March 2026 were VANGUARD CAPITAL MANAGEMENT LLC (719.82K), ADAR1 Capital Management, LLC (374.91K), Blue Owl Capital Holdings LP (351.81K), RA CAPITAL MANAGEMENT, L.P. (248.29K), BlackRock, Inc. (244.22K).
• Top sellers of MPLT stock for the quarter ending March 2026 included T. Rowe Price Investment Management, Inc. (2.8Mn), Goldman Sachs Group Inc (1.88Mn), LAZARD ASSET MANAGEMENT LLC (65.48K), Tetragon Partners GP Ltd (52.41K), Velan Capital Investment Management LP (29.41K).
• Business Quant data shows the 10 biggest positions in MapLight Therapeutics as of March 2026 are held by Novo Holdings A/S (3.69Mn), FCPM III SERVICES B.V. (3.23Mn), T. Rowe Price Investment Management, Inc. (2.8Mn), Goldman Sachs Group Inc (1.99Mn), BlackRock, Inc. (1.34Mn), Blue Owl Capital Holdings LP (1.01Mn), Nan Fung Group Holdings Ltd (971.25K), 5AM Venture Management, LLC (950.01K), Sanofi (912.04K), VANGUARD CAPITAL MANAGEMENT LLC (719.82K).